Life Science Investing Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
Life Science Investing Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results
Locksley Strengthens U.S. Defense Supply Chain Strategy with Appointment of Lockhead Martin Materials Leader to Advisory Board
